Advaxis to Present at the 2017 Barclays Global Healthcare Conference
Mar 13, 2017 12:01 pm UTC| Business
PRINCETON, N.J., March 13, 2017 -- Advaxis, Inc.(NASDAQ:ADXS), a biotechnology company developing cancer immunotherapies, today announced that Sara Bonstein, Chief Financial Officer of Advaxis, will present a corporate...
Advaxis to Present at the 2017 Barclays Global Healthcare Conference
Mar 13, 2017 12:01 pm UTC| Business
PRINCETON, N.J., March 13, 2017 -- Advaxis, Inc.(NASDAQ:ADXS), a biotechnology company developing cancer immunotherapies, today announced that Sara Bonstein, Chief Financial Officer of Advaxis, will present a corporate...
NV5 Awarded Contracts Totaling $11 Million for Energy Services
Mar 13, 2017 12:01 pm UTC| Business
HOLLYWOOD, Fla., March 13, 2017 -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq:NVEE), a provider of professional and technical engineering and consulting solutions, announced today that it was awarded dual...
NV5 Awarded Contracts Totaling $11 Million for Energy Services
Mar 13, 2017 12:01 pm UTC| Business
HOLLYWOOD, Fla., March 13, 2017 -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq:NVEE), a provider of professional and technical engineering and consulting solutions, announced today that it was awarded dual...
Payment Data Systems Announces Intent to Acquire Singular Payments, LLC
Mar 13, 2017 12:01 pm UTC| Business
SAN ANTONIO, March 13, 2017 -- Payment Data Systems (NASDAQ:PYDS), an integrated electronic payment solutions provider, today announced that it has entered into a non-binding Letter of Intent to acquire Singular...
Payment Data Systems Announces Intent to Acquire Singular Payments, LLC
Mar 13, 2017 12:01 pm UTC| Business
SAN ANTONIO, March 13, 2017 -- Payment Data Systems (NASDAQ:PYDS), an integrated electronic payment solutions provider, today announced that it has entered into a non-binding Letter of Intent to acquire Singular...
Mar 13, 2017 12:01 pm UTC| Business
SAN DIEGO, March 13, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders,...